Cargando…
Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis
BACKGROUND: A new histopathological classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis was recently proposed. We evaluated the predictive value of this classification for renal outcome in Japanese patients. METHODS: We enrolled 122 patients with ANCA-associat...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704260/ https://www.ncbi.nlm.nih.gov/pubmed/23773275 http://dx.doi.org/10.1186/1471-2369-14-125 |
_version_ | 1782275973811535872 |
---|---|
author | Iwakiri, Takashi Fujimoto, Shouichi Kitagawa, Kiyoki Furuichi, Kengo Yamahana, Junya Matsuura, Yunosuke Yamashita, Atsushi Uezono, Shigehiro Shimao, Yoshiya Hisanaga, Shuichi Tokura, Takeshi Wada, Takashi Kitamura, Kazuo Asada, Yujiro |
author_facet | Iwakiri, Takashi Fujimoto, Shouichi Kitagawa, Kiyoki Furuichi, Kengo Yamahana, Junya Matsuura, Yunosuke Yamashita, Atsushi Uezono, Shigehiro Shimao, Yoshiya Hisanaga, Shuichi Tokura, Takeshi Wada, Takashi Kitamura, Kazuo Asada, Yujiro |
author_sort | Iwakiri, Takashi |
collection | PubMed |
description | BACKGROUND: A new histopathological classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis was recently proposed. We evaluated the predictive value of this classification for renal outcome in Japanese patients. METHODS: We enrolled 122 patients with ANCA-associated glomerulonephritis diagnosed at several institutions in Japan between January 2000 and March 2010. Twenty patients were excluded because of observation durations of <1 year, and/or because their biopsy specimens contained <10 glomeruli. Renal biopsy specimens were categorized into four classes according to the proposed classification. We evaluated the predictive value of immunohistochemical staining for α-smooth muscle actin (SMA), Wilm’s tumor 1 (WT1), CD68, and cytokeratin for end-stage renal disease (ESRD). RESULTS: The study population included 54 men and 48 women. Age, estimated glomerular filtration rate (eGFR), and proteinuria were 66.3 ± 11.3 years, 21.6 ml/min. and 1.10 g/24 h, respectively. Eighty-six patients were positive for myeloperoxidase-ANCA, five were positive for proteinase 3-ANCA, and 11 were negative for both antibodies. Median follow-up time was 41.0 months. Twenty-three patients (22.5%) developed ESRD during the follow-up period. Twelve patients died during follow up; 7/12 patients developed ESRD before death, and 5/12 patients died without ESRD. The incidence of ESRD increased with sequential categories: focal, 2/46 (4.3%); crescentic, 9/32 (28%); mixed, 8/18 (44%); and sclerotic, 4/6 (67%). The focal class had the best renal survival and the sclerotic class had the worst renal survival (p < 0.001). Kaplan-Meier renal survival analysis was similar to that of the new classification system proposal. In the multivariate analysis, the classification system tended to be a prognostic factor for ESRD (p = 0.0686, crescentic, mixed and sclerotic vs. focal, hazard ratio (HR) [95% confidence interval, CI]; 2.99 [0.61–22.7], 5.04 [1.11–36.4] and 9.93 [1.53–85.7], respectively). α-SMA-positivity also tended to be associated with ESRD (p = 0.1074). CONCLUSION: The new histopathological classification was associated with eGFR at 1 year and tended to be associated with ESRD in our Japanese cohort with ANCA-associated glomerulonephritis. α-SMA positivity might be an additional prognostic factor for ESRD. |
format | Online Article Text |
id | pubmed-3704260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-37042602013-07-09 Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis Iwakiri, Takashi Fujimoto, Shouichi Kitagawa, Kiyoki Furuichi, Kengo Yamahana, Junya Matsuura, Yunosuke Yamashita, Atsushi Uezono, Shigehiro Shimao, Yoshiya Hisanaga, Shuichi Tokura, Takeshi Wada, Takashi Kitamura, Kazuo Asada, Yujiro BMC Nephrol Research Article BACKGROUND: A new histopathological classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis was recently proposed. We evaluated the predictive value of this classification for renal outcome in Japanese patients. METHODS: We enrolled 122 patients with ANCA-associated glomerulonephritis diagnosed at several institutions in Japan between January 2000 and March 2010. Twenty patients were excluded because of observation durations of <1 year, and/or because their biopsy specimens contained <10 glomeruli. Renal biopsy specimens were categorized into four classes according to the proposed classification. We evaluated the predictive value of immunohistochemical staining for α-smooth muscle actin (SMA), Wilm’s tumor 1 (WT1), CD68, and cytokeratin for end-stage renal disease (ESRD). RESULTS: The study population included 54 men and 48 women. Age, estimated glomerular filtration rate (eGFR), and proteinuria were 66.3 ± 11.3 years, 21.6 ml/min. and 1.10 g/24 h, respectively. Eighty-six patients were positive for myeloperoxidase-ANCA, five were positive for proteinase 3-ANCA, and 11 were negative for both antibodies. Median follow-up time was 41.0 months. Twenty-three patients (22.5%) developed ESRD during the follow-up period. Twelve patients died during follow up; 7/12 patients developed ESRD before death, and 5/12 patients died without ESRD. The incidence of ESRD increased with sequential categories: focal, 2/46 (4.3%); crescentic, 9/32 (28%); mixed, 8/18 (44%); and sclerotic, 4/6 (67%). The focal class had the best renal survival and the sclerotic class had the worst renal survival (p < 0.001). Kaplan-Meier renal survival analysis was similar to that of the new classification system proposal. In the multivariate analysis, the classification system tended to be a prognostic factor for ESRD (p = 0.0686, crescentic, mixed and sclerotic vs. focal, hazard ratio (HR) [95% confidence interval, CI]; 2.99 [0.61–22.7], 5.04 [1.11–36.4] and 9.93 [1.53–85.7], respectively). α-SMA-positivity also tended to be associated with ESRD (p = 0.1074). CONCLUSION: The new histopathological classification was associated with eGFR at 1 year and tended to be associated with ESRD in our Japanese cohort with ANCA-associated glomerulonephritis. α-SMA positivity might be an additional prognostic factor for ESRD. BioMed Central 2013-06-17 /pmc/articles/PMC3704260/ /pubmed/23773275 http://dx.doi.org/10.1186/1471-2369-14-125 Text en Copyright © 2013 Iwakiri et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Iwakiri, Takashi Fujimoto, Shouichi Kitagawa, Kiyoki Furuichi, Kengo Yamahana, Junya Matsuura, Yunosuke Yamashita, Atsushi Uezono, Shigehiro Shimao, Yoshiya Hisanaga, Shuichi Tokura, Takeshi Wada, Takashi Kitamura, Kazuo Asada, Yujiro Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis |
title | Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis |
title_full | Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis |
title_fullStr | Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis |
title_full_unstemmed | Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis |
title_short | Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis |
title_sort | validation of a newly proposed histopathological classification in japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704260/ https://www.ncbi.nlm.nih.gov/pubmed/23773275 http://dx.doi.org/10.1186/1471-2369-14-125 |
work_keys_str_mv | AT iwakiritakashi validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis AT fujimotoshouichi validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis AT kitagawakiyoki validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis AT furuichikengo validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis AT yamahanajunya validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis AT matsuurayunosuke validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis AT yamashitaatsushi validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis AT uezonoshigehiro validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis AT shimaoyoshiya validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis AT hisanagashuichi validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis AT tokuratakeshi validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis AT wadatakashi validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis AT kitamurakazuo validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis AT asadayujiro validationofanewlyproposedhistopathologicalclassificationinjapanesepatientswithantineutrophilcytoplasmicantibodyassociatedglomerulonephritis |